Concenter BioPharma Competitors and Similar CompaniesClear all
Concenter BioPharma's competitors and similar companies include Hua Medicine, Enthera Pharmaceuticals, Metabolic Solutions Development and MannKind Corporation.
 Concenter BioPharma Concenter BioPharma is a specialty biopharmaceutical company advancing a pipeline of products that target type 2 diabetes. |  Enthera Pharmaceuticals Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication. |  Metabolic Solutions Development Metabolic Solutions Development Company (MSDC) is a company that discovers and develops molecular targets to treat metabolic diseases. |  MannKind Corporation MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients. | ||
Founding Date | Founding Date 1988 | Founding Date 2011 | Founding Date 2016 | Founding Date 2006 | Founding Date 1991 |
Type | Type Subsidiary | Type Public | Type Private | Type Private | Type Public |
Tags | |||||
Locations | Locations HQ | Locations Shanghai, CN HQ Beijing, CN Wuhan, CN Hong Kong, HK | Locations Milan, IT HQ Milan, IT Milan, IT | Locations Kalamazoo, US HQ | Locations Westlake Village, US HQ Danbury, US |
Employees | Employees 3 | Employees 168 | Employees 225% increase | Employees 13 | Employees 39513% increase |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) ¥492.9m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $349m (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods ¥180.1m (FY, 2025) | Cost of goods N/A | Cost of goods N/A | Cost of goods $26.8m (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit ¥1.6b (FY, 2025) | Gross profit N/A | Gross profit N/A | Gross profit $322.2m (FY, 2025) |
Net income | Net income N/A | Net income ¥1.1b (FY, 2025) | Net income N/A | Net income N/A | Net income $5.9m (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 242.4m | Total funding raised $ 32.8m | Total funding raised $ 42.2m | Total funding raised $ 200m |
For sources of this data, please see the company profile
View Company Profiles
Hua Medicine
HQ
Shanghai, CN
Employees
168
Hua Medicine (华领医药) is a drug development company.
View companyEnthera Pharmaceuticals
HQ
Milan, IT
Employees
22↑ 5% increase
Enthera Pharmaceuticals is a company that develops a biotechnology platform designed to find new therapeutic approaches to treat diabetes and related gastrointestinal complication.
View companyMetabolic Solutions Development
HQ
Kalamazoo, US
Employees
13
Metabolic Solutions Development Company (MSDC) is a company that discovers and develops molecular targets to treat metabolic diseases.
View companyMannKind Corporation
HQ
Westlake Village, US
Employees
395↑ 13% increase
MannKind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for patients.
View company